Literature DB >> 2449496

Functional reactivity of WT31 monoclonal antibody with T cell receptor-gamma expressing CD3+4-8- T cells.

R J van de Griend1, J Borst, W J Tax, R L Bolhuis.   

Abstract

About 3% of normal peripheral blood T lymphocytes have the phenotype CD3+4-8-. The vast majority of these cells lack the conventional TCR-alpha-, beta complex but express the recently identified TCR-gamma, delta/CD3 receptor complex. These TCR gamma+/CD3+ cells were initially discovered by using as a criterion the lack of reactivity with WT31 mAb. This mAb has been reported to recognize a "framework" epitope on the TCR-alpha, beta/CD3 complex. However, using high concentrations of WT31 mAb, low levels of reactivity with the cell membrane of TCR-gamma+ cells can be observed. This reactivity was significantly increased upon removal of sialic acid residues by neuraminidase. In addition, WT31 mAb is capable to induce lysis by TCR-gamma+ clones. Moreover, immunoprecipitation with WT31 by using cell lysates prepared with the mild detergent digitonin resulted in the isolation of the intact TCR-gamma/CD3 complex. Thus, in contrast to what was previously assumed, WT31 mAb also reacts with a functional epitope present on gamma, delta/CD3 T cells, and therefore lack of reactivity with WT31 mAb is not always a proper hallmark for TCR-gamma-expressing cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449496

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Patterns of membrane TcR alpha beta and TcR gamma delta chain expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+ and CD4-CD8- lymphocytes.

Authors:  C S Scott; S J Richards; B E Roberts
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

2.  Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa.

Authors:  L K Trejdosiewicz; C J Smart; D J Oakes; P D Howdle; G Malizia; D Campana; A W Boylston
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

3.  Monoclonal antibodies that identify the CD3 molecules expressed specifically at the surface of porcine gammadelta-T cells.

Authors:  Huaizhi Yang; R Michael E Parkhouse; Thomas Wileman
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

4.  Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor.

Authors:  S E Christmas; A Meager
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

5.  Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection.

Authors:  T Hara; Y Mizuno; K Takaki; H Takada; H Akeda; T Aoki; M Nagata; K Ueda; G Matsuzaki; Y Yoshikai
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Analysis of T cell receptors in rheumatoid arthritis: the increased expression of HLA-DR antigen on circulating gamma delta+ T cells is correlated with disease activity.

Authors:  A Lamour; F Jouen-Beades; O Lees; D Gilbert; X Le Loet; F Tron
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

7.  Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis.

Authors:  R Shimonkevitz; C Colburn; J A Burnham; R S Murray; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  Phenotypic changes and proliferative activity of human gamma delta T cell receptor-bearing cells upon activation.

Authors:  S Ho; D Campana
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

9.  Differential staining of human alpha beta and gamma delta T cells by the fluorescein conjugate of an anti-CD3 monoclonal antibody.

Authors:  J E Mullersman; G White; K S Tung
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

10.  Novel primary thymic defect with T lymphocytes expressing gamma delta T cell receptor.

Authors:  C Geisler; G Pallesen; P Platz; N Odum; E Dickmeiss; L P Ryder; A Svejgaard; T Plesner; J K Larsen; C Koch
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.